MOSCOW (Reuters) – Russia has authorised the one-shot Sputnik Light version of its COVID-19 vaccine for use, the Russian Direct Investment Fund (RDIF) said on Thursday, a move that could help vaccine supplies go further in countries with high infection rates.
Developed by Moscow’s Gamaleya Institute, the slimmed-down vaccine, which the RDIF said is 79.4% effective against COVID-19 and costs under $10 a dose, has been earmarked for export and could increase the number of people with partial immunity.
(Writing by Alexander Marrow; Editing by Nick Macfie)
